INSURANCE & COMMERCE - SENATE - Feb 07, 2023
INSURANCE & COMMERCE - SENATE · February 7, 2023
The Senate Insurance & Commerce Committee heard several bills including SB192 on step-therapy and biosimilars, an amendment to PBM-related licensure provisions that was returned for revision, and HB1042 to align prostate-cancer screening with national guidelines; SB192 and HB1042 were given committee approval to pass.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.